AorTech International plc's (LON:AOR) Bill Brown introduces the company to Proactive London's Andrew Scott.
He says the business is based on a platform technology material called Elast-Eon which he says has been in human use for close to 15 years.
They licence out the tech as well as develop their own products using it.
He says they've now begun the manufacture of heart valves and early prototype valves are currently available for evaluation plus they're also nearing animal trials for its graft development programme.
